Early Rash Development May Signal Superior Benefit With Lapatinib

Early development of rash identified patients with HER2-positive early breast cancer who received superior benefit from lapatinib-based therapy.

PDF) Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

PDF) Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: A systematic review and meta-analysis of randomised controlled trials

Frontiers Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study

PDF) Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial

ErbB2 cellular signaling pathways and lapatinib mechanism of action.

Antibody drug conjugate: the “biological missile” for targeted cancer therapy

Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now, Breast Cancer Research

Frontiers Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

PDF) Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

PDF) Lapatinib in breast cancer

Understanding Beginning Breast Cancer Rash

How long should I wait for a rash to go away on its own before I

Breastfeeding and rashes on breasts: Understanding the causes and

Rashes On Breast During Pregnancy: Causes, Treatment & Prevention

CoppaFeel! on X: Inflammatory breast cancer is a rare type of breast cancer which may cause the skin on the breast to look red or inflamed. The symptoms are caused by cancer